Literature DB >> 21513309

Catalytic mechanism of cytochrome P450 for 5'-hydroxylation of nicotine: fundamental reaction pathways and stereoselectivity.

Dongmei Li1, Xiaoqin Huang, Keli Han, Chang-Guo Zhan.   

Abstract

A series of computational methods were used to study how cytochrome P450 2A6 (CYP2A6) interacts with (S)-(-)-nicotine, demonstrating that the dominant molecular species of (S)-(-)-nicotine in CYP2A6 active site exists in the free base state (with two conformations, SR(t) and SR(c)), despite the fact that the protonated state is dominant for the free ligand in solution. The computational results reveal that the dominant pathway of nicotine metabolism in CYP2A6 is through nicotine free base oxidation. Further, first-principles quantum mechanical/molecular mechanical free energy (QM/MM-FE) calculations were carried out to uncover the detailed reaction pathways for the CYP2A6-catalyzed nicotine 5'-hydroxylation reaction. In the determined CYP2A6-(S)-(-)-nicotine binding structures, the oxygen of Compound I (Cpd I) can abstract a hydrogen from either the trans-5'- or the cis-5'-position of (S)-(-)-nicotine. CYP2A6-catalyzed (S)-(-)-nicotine 5'-hydroxylation consists of two reaction steps, that is, the hydrogen transfer from the 5'-position of (S)-(-)-nicotine to the oxygen of Cpd I (the H-transfer step), followed by the recombination of the (S)-(-)-nicotine moiety with the iron-bound hydroxyl group to generate the 5'-hydroxynicotine product (the O-rebound step). The H-transfer step is rate-determining. The 5'-hydroxylation proceeds mainly with the stereoselective loss of the trans-5'-hydrogen, that is, the 5'-hydrogen trans to the pyridine ring. The calculated overall stereoselectivity of ∼97% favoring the trans-5'-hydroxylation is close to the observed stereoselectivity of 89-94%. This is the first time it has been demonstrated that a CYP substrate exists dominantly in one protonation state (cationic species) in solution, but uses its less-favorable protonation state (neutral free base) to perform the enzymatic reaction.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513309      PMCID: PMC3096943          DOI: 10.1021/ja111657j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  66 in total

1.  Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

Authors:  W Zhang; T Kilicarslan; R F Tyndale; E M Sellers
Journal:  Drug Metab Dispos       Date:  2001-06       Impact factor: 3.922

2.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

3.  The protein backbone makes important contributions to 4-oxalocrotonate tautomerase enzyme catalysis: understanding from theory and experiment.

Authors:  G Andrés Cisneros; Min Wang; Peter Silinski; Michael C Fitzgerald; Weitao Yang
Journal:  Biochemistry       Date:  2004-06-08       Impact factor: 3.162

4.  First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution.

Authors:  Haiting Lu; Xi Chen; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2007-08-11       Impact factor: 2.991

5.  Fundamental reaction pathways for cytochrome P450-catalyzed 5'-hydroxylation and N-demethylation of nicotine.

Authors:  Dongmei Li; Yong Wang; Keli Han; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-07-15       Impact factor: 2.991

6.  Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.

Authors:  H Yamazaki; K Inoue; M Hashimoto; T Shimada
Journal:  Arch Toxicol       Date:  1999-03       Impact factor: 5.153

7.  The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.

Authors:  J W Gorrod; A R Hibberd
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

8.  Metabolic oxidation of nicotine to chemically reactive intermediates.

Authors:  T L Nguyen; L D Gruenke; N Castagnoli
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

9.  Functional and structural changes due to a serine to alanine mutation in the active-site flap of enolase.

Authors:  Russell R Poyner; Todd M Larsen; Se-Wei Wong; George H Reed
Journal:  Arch Biochem Biophys       Date:  2002-05-15       Impact factor: 4.013

10.  Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.

Authors:  Jason K Yano; Mei-Hui Hsu; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  Nat Struct Mol Biol       Date:  2005-08-07       Impact factor: 15.369

View more
  19 in total

1.  The substitution reaction of (CNC)Fe-2N₂ with CO.

Authors:  Hongyan Liu; Shuangshuang Liu; Xiang Zhang
Journal:  J Mol Model       Date:  2013-03-17       Impact factor: 1.810

2.  Binding free energies for nicotine analogs inhibiting cytochrome P450 2A6 by a combined use of molecular dynamics simulations and QM/MM-PBSA calculations.

Authors:  Haiting Lu; Xiaoqin Huang; Mohamed Diwan M AbdulHameed; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2014-03-03       Impact factor: 3.641

3.  Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations.

Authors:  Donghui Wei; Lei Fang; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2013-10-10       Impact factor: 2.991

4.  Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation.

Authors:  Xiaoqin Huang; Guangrong Zheng; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2011-12-20       Impact factor: 2.991

5.  Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin.

Authors:  Donghui Wei; Beilei Lei; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2012-06-14       Impact factor: 15.419

6.  Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).

Authors:  Donghui Wei; Mingsheng Tang; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2015-06-28       Impact factor: 3.876

7.  Reaction pathway and free energy profile for papain-catalyzed hydrolysis of N-acetyl-Phe-Gly 4-nitroanilide.

Authors:  Donghui Wei; Xiaoqin Huang; Junjun Liu; Mingsheng Tang; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2013-07-17       Impact factor: 3.162

Review 8.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

9.  Catalytic Mechanisms for Cofactor-Free Oxidase-Catalyzed Reactions: Reaction Pathways of Uricase-Catalyzed Oxidation and Hydration of Uric Acid.

Authors:  Donghui Wei; Xiaoqin Huang; Yan Qiao; Jingjing Rao; Lu Wang; Fei Liao; Chang-Guo Zhan
Journal:  ACS Catal       Date:  2017-06-15       Impact factor: 13.084

10.  Catalytic mechanism of cytochrome P450 for N-methylhydroxylation of nicotine: reaction pathways and regioselectivity of the enzymatic nicotine oxidation.

Authors:  Dongmei Li; Xiaoqin Huang; Jianping Lin; Chang-Guo Zhan
Journal:  Dalton Trans       Date:  2013-01-09       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.